On December 15, 2021, Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for point-of-care and clinical laboratory markets, entered into a credit agreement with Perceptive Advisors LLC, a investment manager with expertise in healthcare. Pursuant to the credit agreement, among other things, Perceptive agreed to establish a US$81.25 million senior secured term loan credit facility for Trinity and its subsidiaries to refinance certain existing debt. On January 27, 2022, Perceptive advanced the entire facility to Trinity and its subsidiaries.
Cassels acted as Canadian counsel for Perceptive.